EUVIMEDEUVIMED entdecken
Crossref

Past and Future of Patient and Public Involvement and Engagement(PPIE) with a Focus on the Field of Oncology

Shinsuke Amano

Iryo To Shakai · 14.07.2026 · 36 (1) · 103-113

DOI: 10.4091/iken.36-103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iryo To Shakai, erschienen am 14.07.2026. Verfasst von Shinsuke Amano.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patient and Public Involvement and Engagement(PPIE)in the field of oncology originated from the voices of patients and their families calling for the advancement of cancer control measures, which eventually led to the enactment of the Cancer Control Act in 2006. Under this Act, it was mandated that “representatives of cancer patients and their families or bereaved members” be included as members of the Cancer Control Promotion Council within the Ministry of Health, Labour and Welfare, which is responsible for formulating the national Basic Plan to Promote Cancer Control Programs. In the first phase of this Basic Plan, the inclusion of patient perspectives led to significant progress in the equalization of cancer care quality and the establishment of Cancer Information and Support Centers. In the second phase of the Basic Plan to Promote Cancer Control Programs, policies addressing social issues—including the reduction of financial burdens and the promotion of employment for cancer patients—were implemented based on requests from patient members. Furthermore, in response to advocacy from patient organizations, the Cancer Registry Promotion Act and the amended Cancer Control Act were enacted. These legislative milestones led to the advancement of the National Cancer Registry and enhanced measures for rare and intractable cancers. The third phase of the Basic Plan to Promote Cancer Control Programs stipulated that the Japan Agency for Medical Research and Development(AMED)should “initiate efforts to promote cancer research through the involvement of patients and cancer survivors.” Following this, major cancer research groups such as the Japan Clinical Oncology Group(JCOG), as well as private companies, have begun implementing PPIE initiatives starting from the research design stage. In the fiscal year 2025 government budget proposal, a plan to revise the High-Cost Medical Expense Benefit System was presented. However, following advocacy efforts by patient organizations and subsequent deliberations in the Diet, the implementation of this revision was temporarily put on hold.

Zitieren

APA

Amano, S. (2026). Past and Future of Patient and Public Involvement and Engagement(PPIE) with a Focus on the Field of Oncology. Iryo To Shakai, 36(1), 103-113. https://doi.org/10.4091/iken.36-103

Vancouver

Amano S. Past and Future of Patient and Public Involvement and Engagement(PPIE) with a Focus on the Field of Oncology. Iryo To Shakai. 2026;36(1):103-113. doi:10.4091/iken.36-103

BibTeX
@article{Amano2026,
  author = {Amano, Shinsuke},
  title = {Past and Future of Patient and Public Involvement and Engagement(PPIE) with a Focus on the Field of Oncology},
  journal = {Iryo To Shakai},
  year = {2026},
  volume = {36},
  number = {1},
  pages = {103--113},
  doi = {10.4091/iken.36-103}
}
Kostenlos starten →